Nucleic acid therapeutic services
At Axolabs, we specialise in the research, development, analysis and production of oligonucleotide- and mRNA-based therapeutics.
With over 20 years of experience and facilities in Germany and the US, we provide comprehensive services starting from lead identification through clinical trials to commercialisation. As a trusted CDMO partner, we deliver tailored, high-quality solutions, ensuring the efficient advancement of cutting-edge nucleic acid therapies efficiently from early discovery to market.
0
Working with the world's top 10 pharma & biotech companies
0
+
Supported more than 25 clinical programmes
0
+
Employees globally
Analytical services
Our comprehensive analytical services ensure the integrity, purity, and potency of oligonucleotide and mRNA therapeutics. We offer state-of-the-art analytical techniques to support our customers’ drug development process during discovery and clinical programs while supporting IND submission until release of cGMP manufacturing batches, ensuring the highest standards of quality and compliance.
Find out morePreclinical synthesis
We offer preclinical synthesis solutions, producing high-purity oligonucleotides for in vitro and in vivo studies. Our seamless scale-up capabilities ensure consistent quality and support the smooth transition of our customers’ projects from research to clinical phases.
Find out morecGMP manufacturing
Our cGMP manufacturing services are fully compliant with cGMP as interpreted by ICH Harmonised Tripartite Guideline Q7, Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, supporting all phases of clinical development. We provide high-volume production of therapeutic oligonucleotides, ensuring safety, efficacy, and timely delivery of our customers’ therapeutic development pipeline.
Find out moreResearch & development
At the forefront of oligonucleotide innovation, our R&D team collaborates with our customers to design and optimise novel therapeutic modalities, providing in-depth expertise in antisense oligonucleotides, siRNAs, aptamers and more. With expertise in cutting-edge technologies and customised solutions, we drive our customers’ projects from concept to clinical readiness.
Find out moreCustomers
Pharma
Axolabs provides pharmaceutical companies with integrated analytical and manufacturing solutions for therapeutic nucleic acids, supporting every stage from lead discovery to clinical development.
Biotech
We offer biotech companies specialised nucleic acid extraction and purification services, alongside comprehensive support throughout the development of therapeutic nucleic acids.
Research institutes
We deliver complete solutions for research and development, from chemistry and biology to the manufacture of active ingredients in nucleic acid therapeutics.
Venture capitalists
We partner with venture capitalists to advance innovative nucleic acid therapeutic projects, providing the expertise needed to accelerate promising discoveries to clinical readiness.
N-of-1
We support N-of-1 trials by providing tailored nucleic acid solutions that enable personalised medicine approaches, offering precise analytical and manufacturing capabilities to meet the unique needs of individual patient treatments.
Focus areas
Oligonucleotides
Ready to make a difference?
Discover our open roles and find your next opportunity with LGC.